EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

AP ‐1‐Targeting Decoy Oligonucleotides: Mechanisms and Therapeutic Potential as Modulators of Inflammatory Pathways

Maryam Mahjoubin-Tehran, Samaneh Rezaei, Vasily N Sukhorukov, Amin Jalili, Prashant Kesharwani iD, Amirhossein Sahebkar iD

Journal of Cellular and Molecular Medicine · 2026-05 · 30 (9)

DOI: 10.1111/jcmm.71178 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 12.05.2026. Verfasst von Maryam Mahjoubin-Tehran und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Transcription Factor AP-1, Inflammation, Oligonucleotides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Numerous cellular functions, such as apoptosis, proliferation, differentiation, survival, transformation and cell migration, are regulated by a crucial transcription factor called activator protein 1 (AP‐1). Growing evidence indicates that AP‐1 is involved in severe conditions like fibrosis, cancer, and organ damage, as well as inflammatory diseases, including rheumatoid arthritis, psoriasis, and asthma. In recent years, AP‐1 has become a significant focus in drug research. The activation of AP‐1 by TNF is crucial for essential components of the inflammatory reaction, including the expression of tissue remodelling proteases such as collagenase, as well as pro‐inflammatory cell adhesion molecules like E‐selectin. This transcription factor is formed by the assembly of jun‐jun homodimers, jun‐fos heterodimers, and jun‐ATF (Activating Transcription Factor) heterodimers. As a member of the basic leucine zipper (bZIP) class, AP‐1 regulates target genes by binding to their promoters in a sequence‐specific way. New research suggests that reducing AP‐1 function could improve various disease outcomes and treatments. Transfection of decoy oligonucleotides (ODNs) offers an innovative approach to gene therapy by targeting specific gene regulatory elements. Transcription factor decoys mimic the sites where transcription factors bind, competing with promoter regions within the cell nucleus. These molecules can regulate interactions between DNA sequences and transcription factors, which play a role in altering gene activation during both normal and disease‐related cellular processes. This review aims to summarize the effects of AP‐1‐targeted decoys on various conditions. The studies demonstrated the great promising role of AP‐1 decoys as therapeutics for various diseases, especially cardiovascular diseases and cancers. Moreover, it was shown that modifications of AP‐1 (circular and hairpin as well as phosphorothioate backbones structures) decoys made them more stable and effective.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcription Factor AP-1InflammationOligonucleotidesHumansAnimalsSignal TransductionNeoplasms

Stichwörter der Autor:innen

AP‐1cancercardiovascular diseasedecoyoligonucleotidestranscription factors

Substanzen

Transcription Factor AP-1Oligonucleotides

Autor:innen und Institutionen

  • School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Department of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Institute of General Pathology and Pathophysiology, Moscow, Russia.
  • Next-Generation Translational Nanomedicine Laboratory, Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya (A Central University), Sagar, Madhya Pradesh, India.
  • Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Centre for Research Impact & Outcome, Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India.

ORCID-Profile: Prashant Kesharwani, Amirhossein Sahebkar

Förderung

  • Russian Science Foundation

Zitieren

APA

Mahjoubin-Tehran, M., Rezaei, S., Sukhorukov, V. N., Jalili, A., Kesharwani, P., & Sahebkar, A. (2026). AP ‐1‐Targeting Decoy Oligonucleotides: Mechanisms and Therapeutic Potential as Modulators of Inflammatory Pathways. Journal of Cellular and Molecular Medicine, 30(9). https://doi.org/10.1111/jcmm.71178

Vancouver

Mahjoubin-Tehran M, Rezaei S, Sukhorukov VN, Jalili A, Kesharwani P, Sahebkar A. AP ‐1‐Targeting Decoy Oligonucleotides: Mechanisms and Therapeutic Potential as Modulators of Inflammatory Pathways. Journal of Cellular and Molecular Medicine. 2026;30(9). doi:10.1111/jcmm.71178

BibTeX
@article{MahjoubinTehran2026,
  author = {Mahjoubin-Tehran, Maryam and Rezaei, Samaneh and Sukhorukov, Vasily N and Jalili, Amin and Kesharwani, Prashant and Sahebkar, Amirhossein},
  title = {AP ‐1‐Targeting Decoy Oligonucleotides: Mechanisms and Therapeutic Potential as Modulators of Inflammatory Pathways},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2026},
  volume = {30},
  number = {9},
  doi = {10.1111/jcmm.71178}
}
Kostenlos starten →